MeSH D011832 - radiation injuries
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D011830:Radiation effects
0 Companies
0 Drugs
Success rate
D000069079:Radiation exposure
0 Companies
0 Drugs
Success rate
D014947:Wounds and injuries
D011832:
Radiation injuries
D000016:Radiation-induced abnormalities
0 Companies
0 Drugs
Success rate
D000087525:Radiation fibrosis syndrome
0 Companies
0 Drugs
Success rate
D011833:Experimental radiation injuries
D054508:Acute radiation syndrome
0 Companies
0 Drugs
Success rate
D000081015:Ototoxicity
D000081028:Toxic optic neuropathy
0 Companies
0 Drugs
Success rate
D000081030:Myotoxicity
0 Companies
0 Drugs
Success rate
D007953:Radiation-induced leukemia
0 Companies
0 Drugs
Success rate
D009381:Radiation-induced neoplasms
0 Companies
0 Drugs
Success rate
D010025:Osteoradionecrosis
0 Companies
0 Drugs
Success rate
D011855:Radiodermatitis
0 Companies
0 Drugs
Success rate
D017564:Radiation pneumonitis
0 Companies
0 Drugs
Success rate
D066126:Cardiotoxicity
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/6
Phase 3
50%1/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use